- NSE
- CIPLA
- BSE
- 500087
- ISIN
- INE059A01026
CIPLA
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹1,408.30
−₹11.60 (−0.82%)
NSE close ·
CIPLA closed at ₹1,408.30 on 12 Nov 2026, down 0.82% on the day, and is down 7.31% over the past year.
Price history
Between 12 Nov 2025 and 12 Nov 2026, the closing price ranged from ₹1,192.40 to ₹1,535.60.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹1,13,772 Cr
- P/E (TTM)
- 39.3
- Industry P/E
- 35.0
- EPS (TTM)
- ₹35.83
- P/B
- 3.21
- Book value
- ₹438.13
- ROE
- 8.2%
- ROCE
- 11.0%
- Debt/equity
- 0.01
- Operating margin
- 11.4%
- Net margin
- 10.3%
- Dividend yield
- 0.92%
Market cap, P/E, P/B and yield at the 12 Nov 2026 close. TTM: four quarters to 30 Sep 2026 (consolidated). Balance sheet 30 Sep 2026. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Growth | 1Y | 3Y CAGR |
|---|---|---|
| Revenue | −1.81% | +4.73% |
| Net profit | −47.48% | −6.42% |
Trailing twelve months against the same period 1 and 3 years earlier (3Y as a yearly rate); consolidated.
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Sep 2026 | ₹7,555 Cr | ₹852 Cr | −37.08% | ₹10.85 |
| Jun 2026 | ₹7,330 Cr | ₹786 Cr | −39.18% | ₹9.76 |
| Mar 2026 | ₹6,689 Cr | ₹543 Cr | −55.32% | ₹6.86 |
| Dec 2025 | ₹7,281 Cr | ₹674 Cr | −57.18% | ₹8.36 |
| Sep 2025 | ₹7,858 Cr | ₹1,353 Cr | +3.71% | ₹16.72 |
| Jun 2025 | ₹7,216 Cr | ₹1,292 Cr | +9.88% | ₹16.06 |
| Mar 2025 | ₹7,019 Cr | ₹1,214 Cr | +30.29% | ₹15.12 |
| Dec 2024 | ₹7,295 Cr | ₹1,575 Cr | +47.38% | ₹19.43 |
Armor risk check
CIPLA moves about 1.3× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is CIPLA's share price today?
CIPLA (NSE: CIPLA) closed at ₹1,408.30 on 12 Nov 2026, down 0.82% from the previous close of ₹1,419.90. It traded between ₹1,399.50 and ₹1,420.00 that day.
What are CIPLA's 52-week high and low?
Over the last 52 weeks CIPLA traded between ₹1,165.70 and ₹1,539.70, adjusted for splits and bonuses.
What are CIPLA's NSE symbol, BSE code and ISIN?
CIPLA has NSE symbol CIPLA, BSE code 500087, ISIN INE059A01026.
How has CIPLA performed over 1, 3 and 5 years?
CIPLA's share price return: 1Y −7.31%, 3Y +4.33% a year, 5Y +8.98% a year. Dividends are not included.
Does CIPLA pay a dividend?
Yes. CIPLA's latest dividend went ex on 5 Jun 2026: Final · ₹13.00 per share. Dividends over the past year come to a yield of 0.92% at the latest close.
What is CIPLA's P/E ratio?
CIPLA's P/E ratio is 39.3: the ₹1,408.30 close on 12 Nov 2026 over trailing twelve-month EPS of ₹35.83 (consolidated, four quarters to 30 Sep 2026).
What is CIPLA's market cap?
CIPLA's market cap is ₹1,13,772 Cr at the close on 12 Nov 2026.
Which sector is CIPLA in?
CIPLA is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how CIPLA fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app